中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
28期
77-79
,共3页
小儿中性粒细胞减少症%小儿疾病%临床治疗
小兒中性粒細胞減少癥%小兒疾病%臨床治療
소인중성립세포감소증%소인질병%림상치료
Children neutropenia syndrome%Children diseases%Clinical treatment
目的 分析小儿中性粒细胞减少症的临床表现和治疗措施. 方法 随机选取该院2013年2月—2014年4月收治的小儿中性粒细胞减少症患儿60例进行临床分析.将60例患儿分为两组,实验组患儿30例,对照组患儿30例.实验组患儿采用常规的抗病毒药物治疗的基础上,使用利可君升白细胞药物进行治疗. 对照组患者只应用抗病毒药物治疗. 对比两组患儿的治疗有效率, 对比两组患儿在治疗前后白细胞的数量和中性粒细胞绝对值的变化. 结果 实验组患者中有25例患者治愈,有效率为83.33%,对照组患者有19例患者痊愈,有效率为63.33%,实验组患者的有效率明显高于对照组,P<0.05表示差异有统计学意义.结论 小儿中性粒细胞减少症严重的危害小儿的成长发育,临床上主要通过运用抗生素进行预防为主要措施,医生在临床治疗中,尽早的进行诊断,及时的采取有效措施进行能够治疗,能够避免对患儿造成严重的伤害.
目的 分析小兒中性粒細胞減少癥的臨床錶現和治療措施. 方法 隨機選取該院2013年2月—2014年4月收治的小兒中性粒細胞減少癥患兒60例進行臨床分析.將60例患兒分為兩組,實驗組患兒30例,對照組患兒30例.實驗組患兒採用常規的抗病毒藥物治療的基礎上,使用利可君升白細胞藥物進行治療. 對照組患者隻應用抗病毒藥物治療. 對比兩組患兒的治療有效率, 對比兩組患兒在治療前後白細胞的數量和中性粒細胞絕對值的變化. 結果 實驗組患者中有25例患者治愈,有效率為83.33%,對照組患者有19例患者痊愈,有效率為63.33%,實驗組患者的有效率明顯高于對照組,P<0.05錶示差異有統計學意義.結論 小兒中性粒細胞減少癥嚴重的危害小兒的成長髮育,臨床上主要通過運用抗生素進行預防為主要措施,醫生在臨床治療中,儘早的進行診斷,及時的採取有效措施進行能夠治療,能夠避免對患兒造成嚴重的傷害.
목적 분석소인중성립세포감소증적림상표현화치료조시. 방법 수궤선취해원2013년2월—2014년4월수치적소인중성립세포감소증환인60례진행림상분석.장60례환인분위량조,실험조환인30례,대조조환인30례.실험조환인채용상규적항병독약물치료적기출상,사용리가군승백세포약물진행치료. 대조조환자지응용항병독약물치료. 대비량조환인적치료유효솔, 대비량조환인재치료전후백세포적수량화중성립세포절대치적변화. 결과 실험조환자중유25례환자치유,유효솔위83.33%,대조조환자유19례환자전유,유효솔위63.33%,실험조환자적유효솔명현고우대조조,P<0.05표시차이유통계학의의.결론 소인중성립세포감소증엄중적위해소인적성장발육,림상상주요통과운용항생소진행예방위주요조시,의생재림상치료중,진조적진행진단,급시적채취유효조시진행능구치료,능구피면대환인조성엄중적상해.
Objective To analyze the clinical manifestations and treatment of children with neutropenia syndrome. Methods A clinical analysis was performed on 60 children with neutropenia syndrome admitted to this hospital from February 2013 and April 2014. They were divided into experimental group and control group with 30 in each one. Patients in the experimental group were treated with leucogen leucocyte-stimulating agents on the basis of conventional antiviral therapy, while those in the control group underwent conventional antiviral therapy singly. The effective rate and changes of number of white blood cells and absolute value of neutrophil before and after treatment were compared between the two groups. Results 25 patients were cured in the experimen-tal group with an effective rate of 83.33%, while 19 were cured in the control group with an effective rate of 63.33%, and the ef-fective rate was higher in the experiment group than in the control group with statistically significant difference, P<0.05. Conclu-sion Pediatric neutropenia syndrome can adversely impact children's growth and development, and antiviral therapy was mainly performed in its prevention. Early diagnosis and timely treatment through effective measures can reduce its negative influence on children.
